Mindmed completes enrollment of phase 2a trial of mm-120 in adults with attention-deficit/hyperactivity disorder (adhd)

New york--(business wire)---- $mnmd--enrollment completed for mmed007, the phase 2a study evaluating repeated low-dose administration of mm-120 for the treatment of adults with adhd.

MNMD Ratings Summary

MNMD Quant Ranking